Chirospecific and subtype selective dopamine receptor binding of heterocyclic methoxynaphthamide analogs

Arch Pharm (Weinheim). 2005 Jun;338(5-6):276-80. doi: 10.1002/ardp.200400997.

Abstract

Employing the D(3) and D(4) selective methoxynaphthalines nafadotride and FAUC 182, respectively, as lead compounds, the pyrazolo[1,5-a]pyridine-3-carboxamides of type 1a and 2a as well as their 2-substituted regioisomers 1b and 2b were synthesized when following an ex-chiral pool approach. Dopamine receptor binding studies involving the target compounds (1a,b, 2a,b) and the respective optical antipodes ent-1a,b and ent-2a,b revealed the heterocyclic carboxamide 2a as a strong and selective D(4) ligand (K(i) = 8.6 nM). According to a mitogenesis assay, 2a shows D(4) partial agonist effects (29%, EC(50) = 6.7 nM) and, thus, might be of interest for the treatment of sexual dysfunction.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Benzazepines / pharmacology
  • Binding Sites
  • CHO Cells
  • Cricetinae
  • Heterocyclic Compounds / chemistry
  • Heterocyclic Compounds / pharmacology*
  • Humans
  • Mutagenicity Tests / methods
  • Naphthalenes / metabolism*
  • Naphthalenes / pharmacology*
  • Pyrazoles / chemical synthesis
  • Pyrazoles / chemistry
  • Pyrazoles / pharmacology
  • Pyrrolidines / chemistry
  • Pyrrolidines / pharmacology
  • Quantitative Structure-Activity Relationship
  • Rats
  • Receptors, Dopamine / classification
  • Receptors, Dopamine / drug effects*
  • Sexual Dysfunctions, Psychological / drug therapy
  • Spiperone / pharmacology
  • Stereoisomerism*
  • Sulpiride / pharmacology
  • Swine
  • Thymidine / pharmacology
  • Tritium

Substances

  • Benzazepines
  • Heterocyclic Compounds
  • Naphthalenes
  • Pyrazoles
  • Pyrrolidines
  • Receptors, Dopamine
  • Tritium
  • Spiperone
  • Sulpiride
  • Thymidine